HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody 8H9

a murine IgG(1) monoclonal antibody that recognizes cell surface tumor antigen broadly distributed on neuroectodermal, epithelial, and mesenchymal tumors, including rhabdomyosarcoma; may have a potential clinical role in radioimmunotherapy
Also Known As:
8H9 MAb
Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cheung, Nai-Kong V: 3 articles (12/2015 - 10/2005)
2. Edgar, Mark A: 3 articles (06/2014 - 12/2008)
3. Souweidane, Mark M: 3 articles (06/2014 - 12/2008)
4. Luther, Neal: 3 articles (06/2014 - 12/2008)
5. Larson, Steven M: 2 articles (12/2015 - 10/2005)
6. Guo, Hong-Fen: 2 articles (12/2015 - 04/2010)
7. Cheung, Nai-Kong: 2 articles (06/2014 - 04/2010)
8. Gutin, Philip H: 2 articles (04/2010 - 12/2008)
9. Cheng, Ming: 1 article (12/2015)
10. Goldgur, Yehuda: 1 article (12/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Pontine Glioma
4. Rhabdomyosarcoma
5. Neuroblastoma

Related Drugs and Biologics

1. Membrane Proteins (Integral Membrane Proteins)
2. Immunoglobulin G (IgG)
3. Surface Antigens (Surface Antigen)
4. Antigens

Related Therapies and Procedures

1. Radioimmunotherapy